Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low follicle numbers

Bo Yu, Sunni Mumford, G. Donald Royster IV, James Segars, Alicia Y. Armstrong

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective To compare the cost effectiveness of proceeding with oocyte retrieval vs. converting to intrauterine insemination (IUI) in patients with &4 mature follicles during assisted reproductive technology (ART) cycles. Design Probabilistic decision analysis. The cost effectiveness of completing ART cycles in poor responders was compared to that for converting the cycles to IUI. Setting Not applicable. Patient(s) Not applicable. Intervention(s) Cost-effectiveness analysis. Main Outcome Measure(s) Cost effectiveness, which was defined as the average direct medical costs per ongoing pregnancy. Result(s) In patients with 1-3 mature follicles, completing ART was more cost effective if the cost of a single ART cycle was between $10,000 and $25,000. For patients with 4 mature follicles, if an ART cycle cost ;lt18,025, it was more cost effective to continue with oocyte retrieval than to convert to IUI. Conclusion(s) In patients with ;4 mature follicles following ovarian stimulation in ART cycles, it was on average more cost effective to proceed with oocyte retrieval rather than convert to IUI. However, important factors, such as age, prior ART failures, other fertility factors, and medications used in each individual case need to be considered before this analysis model can be adapted by individual practices.

Original languageEnglish (US)
Pages (from-to)435-439
Number of pages5
JournalFertility and Sterility
Volume102
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Assisted Reproductive Techniques
Insemination
Cost-Benefit Analysis
Oocyte Retrieval
Costs and Cost Analysis
Decision Support Techniques
Ovulation Induction
Fertility
Outcome Assessment (Health Care)
Pregnancy

Keywords

  • assisted reproductive technologies
  • cost effectiveness
  • intrauterine insemination
  • Poor responders

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low follicle numbers. / Yu, Bo; Mumford, Sunni; Royster IV, G. Donald; Segars, James; Armstrong, Alicia Y.

In: Fertility and Sterility, Vol. 102, No. 2, 2014, p. 435-439.

Research output: Contribution to journalArticle

Yu, Bo ; Mumford, Sunni ; Royster IV, G. Donald ; Segars, James ; Armstrong, Alicia Y. / Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low follicle numbers. In: Fertility and Sterility. 2014 ; Vol. 102, No. 2. pp. 435-439.
@article{e15764151534469692a312e6cbe0c351,
title = "Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low follicle numbers",
abstract = "Objective To compare the cost effectiveness of proceeding with oocyte retrieval vs. converting to intrauterine insemination (IUI) in patients with &4 mature follicles during assisted reproductive technology (ART) cycles. Design Probabilistic decision analysis. The cost effectiveness of completing ART cycles in poor responders was compared to that for converting the cycles to IUI. Setting Not applicable. Patient(s) Not applicable. Intervention(s) Cost-effectiveness analysis. Main Outcome Measure(s) Cost effectiveness, which was defined as the average direct medical costs per ongoing pregnancy. Result(s) In patients with 1-3 mature follicles, completing ART was more cost effective if the cost of a single ART cycle was between $10,000 and $25,000. For patients with 4 mature follicles, if an ART cycle cost ;lt18,025, it was more cost effective to continue with oocyte retrieval than to convert to IUI. Conclusion(s) In patients with ;4 mature follicles following ovarian stimulation in ART cycles, it was on average more cost effective to proceed with oocyte retrieval rather than convert to IUI. However, important factors, such as age, prior ART failures, other fertility factors, and medications used in each individual case need to be considered before this analysis model can be adapted by individual practices.",
keywords = "assisted reproductive technologies, cost effectiveness, intrauterine insemination, Poor responders",
author = "Bo Yu and Sunni Mumford and {Royster IV}, {G. Donald} and James Segars and Armstrong, {Alicia Y.}",
year = "2014",
doi = "10.1016/j.fertnstert.2014.05.015",
language = "English (US)",
volume = "102",
pages = "435--439",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low follicle numbers

AU - Yu, Bo

AU - Mumford, Sunni

AU - Royster IV, G. Donald

AU - Segars, James

AU - Armstrong, Alicia Y.

PY - 2014

Y1 - 2014

N2 - Objective To compare the cost effectiveness of proceeding with oocyte retrieval vs. converting to intrauterine insemination (IUI) in patients with &4 mature follicles during assisted reproductive technology (ART) cycles. Design Probabilistic decision analysis. The cost effectiveness of completing ART cycles in poor responders was compared to that for converting the cycles to IUI. Setting Not applicable. Patient(s) Not applicable. Intervention(s) Cost-effectiveness analysis. Main Outcome Measure(s) Cost effectiveness, which was defined as the average direct medical costs per ongoing pregnancy. Result(s) In patients with 1-3 mature follicles, completing ART was more cost effective if the cost of a single ART cycle was between $10,000 and $25,000. For patients with 4 mature follicles, if an ART cycle cost ;lt18,025, it was more cost effective to continue with oocyte retrieval than to convert to IUI. Conclusion(s) In patients with ;4 mature follicles following ovarian stimulation in ART cycles, it was on average more cost effective to proceed with oocyte retrieval rather than convert to IUI. However, important factors, such as age, prior ART failures, other fertility factors, and medications used in each individual case need to be considered before this analysis model can be adapted by individual practices.

AB - Objective To compare the cost effectiveness of proceeding with oocyte retrieval vs. converting to intrauterine insemination (IUI) in patients with &4 mature follicles during assisted reproductive technology (ART) cycles. Design Probabilistic decision analysis. The cost effectiveness of completing ART cycles in poor responders was compared to that for converting the cycles to IUI. Setting Not applicable. Patient(s) Not applicable. Intervention(s) Cost-effectiveness analysis. Main Outcome Measure(s) Cost effectiveness, which was defined as the average direct medical costs per ongoing pregnancy. Result(s) In patients with 1-3 mature follicles, completing ART was more cost effective if the cost of a single ART cycle was between $10,000 and $25,000. For patients with 4 mature follicles, if an ART cycle cost ;lt18,025, it was more cost effective to continue with oocyte retrieval than to convert to IUI. Conclusion(s) In patients with ;4 mature follicles following ovarian stimulation in ART cycles, it was on average more cost effective to proceed with oocyte retrieval rather than convert to IUI. However, important factors, such as age, prior ART failures, other fertility factors, and medications used in each individual case need to be considered before this analysis model can be adapted by individual practices.

KW - assisted reproductive technologies

KW - cost effectiveness

KW - intrauterine insemination

KW - Poor responders

UR - http://www.scopus.com/inward/record.url?scp=84905501215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905501215&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2014.05.015

DO - 10.1016/j.fertnstert.2014.05.015

M3 - Article

C2 - 24951366

AN - SCOPUS:84905501215

VL - 102

SP - 435

EP - 439

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -